This educational activity is designed to highlight innovation, discovery, or updates in medical science with an emphasis on how these apply to diagnosis, treatment, or outcomes in clinical care of the pediatric patient. It also disseminates current changes in health care policies and trends in health care education and professionalism. Education is provided by speakers that present basic science in such a way that is educational and relevant to a general clinician. Speakers provide updates on clinical guidelines for diagnosis and treatment using evidence-based medicine from the literature and leading experts. On topics of health care policies, epidemiologic changes and population health, or health care education or professionalism, specific speakers are sought for their expertise and present in these areas. Invited speakers from other academic institutions, as well as internal MCW faculty, form the PGR speaker roster.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- Physician (fellows/residents)
- Physician Assistants
- Nurse Practitioners
- Social Workers
Participants who engage in this educational intervention will be able to:
• Review therapies for relapsed Hodgkin lymphoma in pediatrics and adults
• Describe the rational and process of development of a clinical trial for relapsed Hodgkin lymphoma
• Summarize the outcomes and toxicities of an international clinical trial for relapsed Hodgkin lymphoma
• Measurable outcome: to gain greater knowledge of clinical trial design, and the role of immunotherapy and targeted therapy in pediatric Hodgkin lymphoma
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Paul Harker-Murray, MD, PhD,
Section Chief for Hematology, Oncology and Bone Marrow Transplant, Children’s Wisconsin;
Associate Professor, Quality Improvement Value Champion, Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplant, Medical College of Wisconsin
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.